Group One Trading’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-278,300
| Closed | -$8.25M | – | 8259 |
|
|
2023
Q4 | $8.25M | Sell |
278,300
-135,000
| -33% | -$2.69M | 0.02% | 808 |
|
|
2023
Q3 | $6.56M | Buy |
413,300
+200,400
| +94% | +$3.33M | 0.02% | 767 |
|
|
2023
Q2 | $4.02M | Buy |
212,900
+39,400
| +23% | +$465K | 0.01% | 1137 |
|
|
2023
Q1 | $666K | Buy |
173,500
+163,500
| +1,635% | +$697K | ﹤0.01% | 2492 |
|
|
2022
Q4 | $49.6K | Sell |
10,000
-26,300
| -72% | -$143K | ﹤0.01% | 4998 |
|
|
2022
Q3 | $174K | Buy |
36,300
+10,400
| +40% | +$54.8K | ﹤0.01% | 4278 |
|
|
2022
Q2 | $117K | Buy |
25,900
+6,100
| +31% | +$26.5K | ﹤0.01% | 4834 |
|
|
2022
Q1 | $94K | Buy |
19,800
+4,200
| +27% | +$23.3K | ﹤0.01% | 5554 |
|
|
2021
Q4 | $116K | Sell |
15,600
-4,800
| -24% | -$29.8K | ﹤0.01% | 5604 |
|
|
2021
Q3 | $116K | Buy |
20,400
+15,800
| +343% | +$91.3K | ﹤0.01% | 5765 |
|
|
2021
Q2 | $30K | Buy |
4,600
+1,600
| +53% | +$11.2K | ﹤0.01% | 6963 |
|
|
2021
Q1 | $24K | Sell |
3,000
-149,100
| -98% | -$1.22M | ﹤0.01% | 6687 |
|
|
2020
Q4 | $981K | Buy |
152,100
+149,700
| +6,238% | +$873K | ﹤0.01% | 2658 |
|
|
2020
Q3 | $9K | Sell |
2,400
-24,800
| -91% | -$100K | ﹤0.01% | 5476 |
|
|
2020
Q2 | $125K | Buy |
27,200
+11,700
| +75% | +$49.8K | ﹤0.01% | 3740 |
|
|
2020
Q1 | $53K | Buy |
15,500
+2,800
| +22% | +$12.2K | ﹤0.01% | 3678 |
|
|
2019
Q4 | $65K | Buy |
12,700
+6,900
| +119% | +$23.4K | ﹤0.01% | 3888 |
|
|
2019
Q3 | $14K | Sell |
5,800
-80,900
| -93% | -$215K | ﹤0.01% | 4493 |
|
|
2019
Q2 | $188K | Sell |
86,700
-213,200
| -71% | -$504K | ﹤0.01% | 2901 |
|
|
2019
Q1 | $813K | Buy |
299,900
+219,300
| +272% | +$950K | 0.01% | 1557 |
|
|
2018
Q4 | $387K | Buy |
80,600
+69,300
| +613% | +$421K | ﹤0.01% | 2167 |
|
|
2018
Q3 | $107K | Sell |
11,300
-195,600
| -95% | -$1.88M | ﹤0.01% | 3488 |
|
|
2018
Q2 | $2.01M | Buy |
206,900
+27,000
| +15% | +$285K | 0.02% | 1127 |
|
|
2018
Q1 | $1.89M | Buy |
179,900
+173,900
| +2,898% | +$1.72M | 0.02% | 1042 |
|
|
2017
Q4 | $38K | Sell |
6,000
-140,000
| -96% | -$863K | ﹤0.01% | 3870 |
|
|
2017
Q3 | $1.12M | Buy |
146,000
+109,000
| +295% | +$724K | 0.01% | 1478 |
|
|
2017
Q2 | $263K | Sell |
37,000
-18,600
| -33% | -$85.1K | ﹤0.01% | 2443 |
|
|
2017
Q1 | $215K | Sell |
55,600
-89,300
| -62% | -$261K | ﹤0.01% | 2479 |
|
|
2016
Q4 | $296K | Buy |
144,900
+22,200
| +18% | +$44.6K | ﹤0.01% | 2141 |
|
|
2016
Q3 | $329K | Buy |
122,700
+97,000
| +377% | +$282K | ﹤0.01% | 2130 |
|
|
2016
Q2 | $79K | Buy |
25,700
+20,400
| +385% | +$128K | ﹤0.01% | 3026 |
|
|
2016
Q1 | $45K | Sell |
5,300
-11,100
| -68% | -$93.9K | ﹤0.01% | 3315 |
|
|
2015
Q4 | $223K | Sell |
16,400
-26,800
| -62% | -$330K | ﹤0.01% | 2421 |
|
|
2015
Q3 | $415K | Buy |
43,200
+26,700
| +162% | +$390K | 0.01% | 1929 |
|
|
2015
Q2 | $237K | Sell |
16,500
-119,500
| -88% | -$1.31M | ﹤0.01% | 2402 |
|
|
2015
Q1 | $1.22M | Buy |
136,000
+89,600
| +193% | +$649K | 0.02% | 928 |
|
|
2014
Q4 | $283K | Buy |
46,400
+26,300
| +131% | +$241K | ﹤0.01% | 2018 |
|
|
2014
Q3 | $213K | Buy |
20,100
+14,300
| +247% | +$162K | ﹤0.01% | 2324 |
|
|
2014
Q2 | $69K | Sell |
5,800
-24,500
| -81% | -$308K | ﹤0.01% | 3318 |
|
|
2014
Q1 | $452K | Sell |
30,300
-28,200
| -48% | -$445K | 0.01% | 1716 |
|
|
2013
Q4 | $858K | Buy |
58,500
+9,000
| +18% | +$138K | 0.01% | 1207 |
|
|
2013
Q3 | $842K | Buy |
49,500
+22,700
| +85% | +$399K | 0.02% | 1142 |
|
|
2013
Q2 | $445K | Buy |
+26,800
| New | +$434K | 0.01% | 1446 |
|
Other funds holding IMGN
Group One Trading's IMGN Position: Q4 2023 in Review
Group One Trading sold out of Immunogen Inc (IMGN) in Q4 2023, closing a stake of 238,327 shares — an estimated $4.75M sold.
Group One Trading first reported a position in IMGN in Q2 2013 and held it in 33 quarters. The position peaked at $3.78M in Q3 2023. 327 funds tracked by Wall St. Rank hold IMGN as of Q4 2023.
- Group One Trading reported no remaining Immunogen Inc position as of Q4 2023 after selling out during the quarter.
- Group One Trading sold 238,327 Immunogen Inc shares in Q4 2023, an estimated $4.75M.
- Group One Trading first reported a position in Immunogen Inc in Q2 2013 and held it in 33 quarters.
- Group One Trading's Immunogen Inc position peaked at $3.78M in Q3 2023.
- 327 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2023.
Based on Group One Trading's 13F filing for Q4 2023, filed 14 Feb 2024.